Understanding how cells stop dividing and enter a resting state

Probing the flexibility of G0

NIH-funded research University of Michigan at Ann Arbor · NIH-10890583

This study is looking at how cells take breaks from dividing and what makes them start dividing again, which is important for keeping our tissues healthy and could help us understand diseases like cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor NIH-funded
Lab location1 site (Ann Arbor, United States)
Project IDNIH-10890583 on NIH RePORTER

What this research studies

This research investigates the mechanisms that control the cell cycle, particularly focusing on the G0 phase where cells enter a non-dividing state. It aims to uncover how cells decide to stop dividing during development and how they can re-enter the cell cycle in response to various signals. By studying different states of G0, the research seeks to understand the physiological roles of quiescent cells and their importance in tissue health and regeneration. This could provide insights into how disruptions in these processes may lead to diseases such as cancer.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with conditions related to abnormal cell growth or those interested in the biological processes of aging.

Not a fit: Patients with stable, non-cancerous conditions that do not involve cell cycle dysregulation may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating cancers and other conditions related to cell cycle regulation.

How similar studies have performed: Previous research has shown promising results in understanding cell cycle regulation, but this specific focus on the G0 phase is relatively novel.

Where this research is happening

Ann Arbor, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.